Advanced Clinical Joins Decentralized Trials & Research Alliance (DTRA) to Democratize and Accelerate Clinical Trials
“We are excited to join DTRA to help shape the innovative approach to clinical trial design and conduct,” said Julie Ross, President of Advanced Clinical. “Decentralized trials provide access to diverse groups of patients and physicians, which in turn bring therapies that better reflect all people to the market rapidly. This is in strong alignment with our company mission to make a difference by improving all lives and providing hope.”
“We are extremely gratified to welcome Advanced Clinical to the ‘Decentralized Trials & Research Alliance," said Amir Kalali, MD, founder of several collaborative life science communities, and co-convener of DTRA. “By advancing decentralized research we can make the clinical trial process more patient-focused, increase trial efficiency and encourage use of technologies. We are excited by Advanced Clinical’s commitment to embracing decentralized trials and to changing the culture that has been the rate limiter to innovation.”
Experts estimate that COVID-19 may set back non-pandemic clinical trials by several years due to prospective patients’ inability or reluctance to schedule visits at physical research locations. Decentralized approaches to conducting research facilitate participation by a more diverse patient population and could ease COVID-19-imposed difficulties for both patients and clinical investigators. Inclusion of representative patient populations in clinical trials by race, age and geographic location has long been an operational challenge. COVID-19 has amplified the disparities and inclusion biases that have become hurdles for potential trial participants.
"Now is the time to share ideas and insights that will chart the future course of clinical trials, accelerating drug development and saving lives – and by taking part in the DTRA, Advanced Clinical is demonstrating its leadership to drive change," said Craig Lipset, DTRA co-convener, clinical innovation advisor, and a pioneer in decentralized trials. “We have a responsibility to advance the health of people with unmet medical needs, and by convening stakeholders from pharma companies, regulators, technology leaders and patient communities we can remove remaining barriers to adoption and impact patients today.”
Advanced Clinical joins with its peer DTRA Member organizations to provide expertise to identify and address gaps and needs and advance best practices through effective education and communication. (Member Organization) urges other organizations interested in taking part to visit DTRA.org
About Advanced Clinical:
Advanced Clinical is a global clinical research services organization that provides CRO, FSP and Strategic Resourcing services for biopharmaceutical and medical device organizations. Our mission is to deliver a better clinical experience. To learn more, visit www.advancedclinical.com.
The Decentralized Trials & Research Alliance (DTRA) was convened to enable collaboration of stakeholders to accelerate the adoption of patient-focused, decentralized clinical trials and research within life sciences and healthcare through education and research. It works to make research participation accessible to everyone, enabled by the consistent, widespread adoption of appropriate decentralized research methods. Follow DTRA on Twitter and LinkedIn for more information.
Director of Marketing
Source: Advanced Clinical